Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Effectiveness of Upadacitinib on Early and Sustained Pain Control in Axial Spondylarthritis (UPSTAND)

NCT04846244 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04846244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04846244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Effectiveness of Upadacitinib on Early and Sustained Pain Control in Axial Spondylarthritis (UPSTAND)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
April 30, 2021
Completion date
March 24, 2025
Enrollment
708 (actual)
Sites
160

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondylarthritis (axspa)